GFACX
Price
$71.94
Change
+$0.24 (+0.33%)
Updated
Jul 25 closing price
Net Assets
328.1B
LDVCX
Price
$27.35
Change
+$0.15 (+0.55%)
Updated
Jul 25 closing price
Net Assets
111.84M
Interact to see
Advertisement

GFACX vs LDVCX

Header iconGFACX vs LDVCX Comparison
Open Charts GFACX vs LDVCXBanner chart's image
American Funds Growth Fund of Amer C
Price$71.94
Change+$0.24 (+0.33%)
VolumeN/A
Net Assets328.1B
AXS FTSE Vntr Cptl RetTrckr C
Price$27.35
Change+$0.15 (+0.55%)
VolumeN/A
Net Assets111.84M
GFACX vs LDVCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. LDVCX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and LDVCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 328B vs. LDVCX (112M). GFACX (0.00) and LDVCX (0.00) have matching dividends . GFACX was incepted earlier than LDVCX: GFACX (24 years) vs LDVCX (10 years). LDVCX (2.72) is less costly to investors than GFACX (1.36). LDVCX is a more actively managed with annual turnover of: 29.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than LDVCX: GFACX (250) vs LDVCX (2500). LDVCX annual gain was more profitable for investors over the last year : 42.67 vs. GFACX (15.45). GFACX return over 5 years is better than : 38.85 vs. LDVCX (10.97).
GFACXLDVCXGFACX / LDVCX
Total Expense Ratio1.362.5054%
Annual Report Gross Expense Ratio1.362.7250%
Fund Existence24 years10 years-
Gain YTD12.82919.58965%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets328B112M292,857%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.4542.6736%
Returns for 3 years51.55114.5145%
Returns for 5 years38.8510.97354%
Returns for 10 years67.89N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLD130.834.00
+3.15%
Steel Dynamics
TSHA2.650.06
+2.32%
Taysha Gene Therapies
DORM122.050.49
+0.40%
Dorman Products
TPIC0.89N/A
N/A
TPI Composites
LIXT4.11-0.18
-4.20%
Lixte Biotechnology Holdings